Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2014, Article ID 623856, 8 pages
http://dx.doi.org/10.1155/2014/623856
Review Article

Three-Dimensional In Vitro Models of Granuloma to Study Bacteria-Host Interactions, Drug-Susceptibility, and Resuscitation of Dormant Mycobacteria

Department of Animal Health, Basque Institute for Agricultural Research and Development, NEIKER-Tecnalia, Technological Park of Bizkaia, Derio, 48160 Bizkaia, Spain

Received 18 October 2013; Accepted 16 April 2014; Published 21 May 2014

Academic Editor: Edouard Tuaillon

Copyright © 2014 Liam E. Fitzgerald et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. L. Flynn and J. Chan, “Tuberculosis: latency and reactivation,” Infection and Immunity, vol. 69, no. 7, pp. 4195–4201, 2001. View at Publisher · View at Google Scholar · View at Scopus
  2. P. Tiruviluamala and L. B. Reichman, “Tuberculosis,” Annual Review of Public Health, vol. 23, pp. 403–426, 2002. View at Publisher · View at Google Scholar · View at Scopus
  3. WHO, “Fact sheet no. 104,” 2013, http://www.who.int/mediacentre/factsheets/fs104/en/.
  4. R. J. Montali, S. K. Mikota, and L. I. Cheng, “Mycobacterium tuberculosis in zoo and wildlife species,” Revue Scientifique et Technique, vol. 20, no. 1, pp. 291–303, 2001. View at Google Scholar · View at Scopus
  5. P. Oh, R. Granich, J. Scott et al., “Human exposure following Mycobacterium tuberculosis infection of multiple animal species in a metropolitan zoo,” Emerging Infectious Diseases, vol. 8, no. 11, pp. 1290–1293, 2002. View at Google Scholar · View at Scopus
  6. S. K. Mikota and J. N. Maslow, “Tuberculosis at the human-animal interface: an emerging disease of elephants,” Tuberculosis, vol. 91, no. 3, pp. 208–211, 2011. View at Publisher · View at Google Scholar · View at Scopus
  7. A. Fanning, S. Edwards, and G. Hauer, “Mycobacterium bovis infection in humans exposed to elk in Alberta,” Canada Diseases Weekly Report, vol. 17, no. 44, pp. 239–243, 1991. View at Google Scholar · View at Scopus
  8. J. R. Dalovisio, M. Stetter, and S. Mikota-Wells, “Rhinoceros' rhinorrhea: cause of an outbreak of infection due to airborne Mycobacterium bovis in zookeepers,” Clinical Infectious Diseases, vol. 15, no. 4, pp. 598–600, 1992. View at Google Scholar · View at Scopus
  9. F. D. Menzies and S. D. Neill, “Cattle-to-cattle transmission of bovine tuberculosis,” The Veterinary Journal, vol. 160, no. 2, pp. 92–106, 2000. View at Publisher · View at Google Scholar · View at Scopus
  10. “Cat-to-human transmission of bovine TB: risk to public “very low’,” Veterinary Record: News and Reports, vol. 174, no. 14, article 337, 2014. View at Publisher · View at Google Scholar
  11. S. L. Ott, S. J. Wells, and B. A. Wagner, “Herd-level economic losses associated with Johne's disease on US dairy operations,” Preventive Veterinary Medicine, vol. 40, no. 3-4, pp. 179–192, 1999. View at Publisher · View at Google Scholar · View at Scopus
  12. S. S. Nielsen and N. Toft, “A review of prevalences of paratuberculosis in farmed animals in Europe,” Preventive Veterinary Medicine, vol. 88, no. 1, pp. 1–14, 2009. View at Publisher · View at Google Scholar · View at Scopus
  13. S. A. Naser, G. Ghobrial, C. Romero, and J. F. Valentine, “Culture of Mycobacterium avium subspecies paratuberculosis from the blood of patients with Crohn's disease,” The Lancet, vol. 364, no. 9439, pp. 1039–1044, 2004. View at Publisher · View at Google Scholar · View at Scopus
  14. R. B. Gearry, J. M. Aitken, R. L. Roberts, S. Ismail, J. Keenan, and M. L. Barclay, “Images of interest. Gastrointestinal: Mycobacterium avium paratuberculosis and Crohn’s disease,” Journal of Gastroenterology and Hepatology, vol. 20, no. 12, Article ID 1943, 2005. View at Google Scholar
  15. A. M. Scanu, T. J. Bull, S. Cannas et al., “Mycobacterium avium subspecies paratuberculosis infection in cases of irritable bowel syndrome and comparison with Crohn's disease and Johne's disease: common neural and immune pathogenicities,” Journal of Clinical Microbiology, vol. 45, no. 12, pp. 3883–3890, 2007. View at Publisher · View at Google Scholar · View at Scopus
  16. R. A. Juste, N. Elguezabal, J. M. Garrido et al., “On the prevalence of M. avium subspecies paratuberculosis DNA in the blood of healthy individuals and patients with inflammatory bowel disease,” PLoS ONE, vol. 3, no. 7, article e2537, 2008. View at Publisher · View at Google Scholar · View at Scopus
  17. R. A. Juste, N. Elguezabal, A. Pavón et al., “Association between Mycobacterium avium subsp. paratuberculosis DNA in blood and cellular and humoral immune response in inflammatory bowel disease patients and controls,” International Journal of Infectious Diseases, vol. 13, no. 2, pp. 247–254, 2009. View at Publisher · View at Google Scholar · View at Scopus
  18. I. Abubakar, D. Myhill, S. H. Aliyu, and P. R. Hunter, “Detection of Mycobacterium avium subspecies paratubercubsis from patients with Crohn's disease using nucleic acid-based techniques: a systematic review and meta-analysis,” Inflammatory Bowel Diseases, vol. 14, no. 3, pp. 401–410, 2008. View at Publisher · View at Google Scholar · View at Scopus
  19. M. Feller, K. Huwiler, R. Stephan et al., “Mycobacterium avium subspecies paratuberculosis and Crohn's disease: a systematic review and meta-analysis,” The Lancet Infectious Diseases, vol. 7, no. 9, pp. 607–613, 2007. View at Publisher · View at Google Scholar · View at Scopus
  20. WHO, “Leprosy: global situation,” 2012, http://www.who.int/lep/situation/en/.
  21. S. Bruce, T. L. Schroeder, K. Ellner, H. Rubin, T. Williams, and J. E. Wolf Jr., “Armadillo exposure and Hansen's disease: an epidemiologic survey in southern Texas,” Journal of the American Academy of Dermatology, vol. 43, no. 2, part 1, pp. 223–228, 2000. View at Google Scholar · View at Scopus
  22. B. M. Clark, C. K. Murray, L. L. Horvath, G. A. Deye, M. S. Rasnake, and R. N. Longfield, “Case-control study of armadillo contact and Hansen's disease,” American Journal of Tropical Medicine and Hygiene, vol. 78, no. 6, pp. 926–927, 2008. View at Google Scholar · View at Scopus
  23. O. Rojas-Espinosa and M. Løvik, “Mycobacterium leprae and Mycobacterium lepraemurium infections in domestic and wild animals,” Revue Scientifique et Technique, vol. 20, no. 1, pp. 219–251, 2001. View at Google Scholar · View at Scopus
  24. D. G. Russell, “Mycobacterium tuberculosis: here today, and here tomorrow,” Nature Reviews Molecular Cell Biology, vol. 2, no. 8, pp. 569–577, 2001. View at Publisher · View at Google Scholar · View at Scopus
  25. D. G. Russell, P.J. Cardona, M.J. Kim, S. Allain, and F. Altare, “Foamy macrophages and the progression of the human tuberculosis granuloma,” Nature Immunology, vol. 10, no. 9, pp. 943–948, 2009. View at Publisher · View at Google Scholar · View at Scopus
  26. L. Ramakrishnan, “Revisiting the role of the granuloma in tuberculosis,” Nature Reviews Immunology, vol. 12, no. 5, pp. 352–366, 2012. View at Publisher · View at Google Scholar · View at Scopus
  27. Z. Toossi and J. J. Ellner, “Host response to Mycobacterium tuberculosis,” Frontiers in Bioscience, vol. 25, no. 3, pp. 133–140, 1998. View at Google Scholar
  28. B. M. Saunders and A. M. Cooper, “Restraining mycobacteria: role of granulomas in mycobacterial infections,” Immunology and Cell Biology, vol. 78, no. 4, pp. 334–341, 2000. View at Publisher · View at Google Scholar · View at Scopus
  29. N. J. Garton, H. Christensen, D. E. Minnikin, R. A. Adegbola, and M. R. Barer, “Intracellular lipophilic inclusions of mycobacteria in vitro and in sputum,” Microbiology, vol. 148, no. 10, pp. 2951–2958, 2002. View at Google Scholar · View at Scopus
  30. J. E. Gomez and J. D. McKinney, “M. tuberculosis persistence, latency, and drug tolerance,” Tuberculosis, vol. 84, no. 1-2, pp. 29–44, 2004. View at Publisher · View at Google Scholar · View at Scopus
  31. A. Bhatt, V. Molle, G. S. Besra, W. R. Jacobs Jr., and L. Kremer, “The Mycobacterium tuberculosis FAS-II condensing enzymes: their role in mycolic acid biosynthesis, acid-fastness, pathogenesis and in future drug development,” Molecular Microbiology, vol. 64, no. 6, pp. 1442–1454, 2007. View at Publisher · View at Google Scholar · View at Scopus
  32. P. Peyron, J. Vaubourgeix, Y. Poquet et al., “Foamy macrophages from tuberculous patients' granulomas constitute a nutrient-rich reservoir for M. tuberculosis persistence,” PLoS Pathogens, vol. 4, no. 11, article e1000204, 2008. View at Publisher · View at Google Scholar · View at Scopus
  33. J. Daniel, H. Maamar, C. Deb, T. D. Sirakova, and P. E. Kolattukudy, “Mycobacterium tuberculosis uses host triacylglycerol to accumulate lipid droplets and acquires a dormancy-like phenotype in lipid-loaded macrophages,” PLoS Pathogens, vol. 7, no. 6, article e1002093, 2011. View at Publisher · View at Google Scholar · View at Scopus
  34. E. Guirado and L. S. Schlesinger, “Modeling the Mycobacterium tuberculosis granuloma—the critical battlefield in host immunity and disease,” Frontiers in Immunology, vol. 4, article 98, p. 98, 2013. View at Publisher · View at Google Scholar
  35. M. Sandor, J. V. Weinstock, and T. A. Wynn, “Granulomas in schistosome and mycobacterial infections: a model of local immune responses,” Trends in Immunology, vol. 24, no. 1, pp. 44–52, 2003. View at Publisher · View at Google Scholar · View at Scopus
  36. J. M. Tufariello, J. Chan, and J. L. Flynn, “Latent tuberculosis: mechanisms of host and bacillus that contribute to persistent infection,” The Lancet Infectious Diseases, vol. 3, no. 9, pp. 578–590, 2003. View at Publisher · View at Google Scholar · View at Scopus
  37. T. T. Yoshikawa, “Tuberculosis in aging adults,” Journal of the American Geriatrics Society, vol. 40, no. 2, pp. 178–187, 1992. View at Google Scholar · View at Scopus
  38. O. C. Turner, R. G. Keefe, I. Sugawara, H. Yamada, and I. M. Orme, “SWR mice are highly susceptible to pulmonary infection with Mycobacterium tuberculosis,” Infection and Immunity, vol. 71, no. 9, pp. 5266–5272, 2003. View at Publisher · View at Google Scholar · View at Scopus
  39. D. M. Bouley, N. Ghori, K. L. Mercer, S. Falkow, and L. Ramakrishnan, “Dynamic nature of host-pathogen interactions in Mycobacterium marinum granulomas,” Infection and Immunity, vol. 69, no. 12, pp. 7820–7831, 2001. View at Publisher · View at Google Scholar · View at Scopus
  40. J. M. Davis and L. Ramakrishnan, “The role of the granuloma in expansion and dissemination of early tuberculosis infection,” Cell, vol. 136, no. 1, pp. 37–49, 2009. View at Publisher · View at Google Scholar · View at Scopus
  41. H. M. Algood, J. Chan, and J. L. Flynn, “Chemokines and tuberculosis,” Cytokine & Growth Factor Reviews, vol. 14, no. 6, pp. 467–477, 2003. View at Publisher · View at Google Scholar · View at Scopus
  42. I. M. Orme and A. M. Cooper, “Cytokine/chemokine cascades in immunity to tuberculosis,” Immunology Today, vol. 20, no. 7, pp. 307–312, 1999. View at Publisher · View at Google Scholar · View at Scopus
  43. V. Lazarevic, D. Nolt, and J. L. Flynn, “Long-term control of Mycobacterium tuberculosis infection is mediated by dynamic immune responses,” The Journal of Immunology, vol. 175, no. 2, pp. 1107–1117, 2005. View at Google Scholar · View at Scopus
  44. M. L. Bourigault, R. Vacher, S. Rose, M. L. Olleros et al., “Tumor necrosis factor neutralization combined with chemotherapy enhances Mycobacterium tuberculosis clearance and reduces lung pathology,” Journal of Clinical and Experimental Immunology, vol. 2, no. 1, pp. 124–134, 2013. View at Google Scholar
  45. D. R. Roach, A. G. Bean, C. Demangel, M. P. France, H. Briscoe, and W. J. Britton, “TNF regulates chemokine induction essential for cell recruitment, granuloma formation, and clearance of mycobacterial infection,” The Journal of Immunology, vol. 168, no. 9, pp. 4620–4627, 2002. View at Google Scholar · View at Scopus
  46. S. Marino, D. Sud, H. Plessner et al., “Differences in reactivation of tuberculosis induced from anti-TNF treatments are based on bioavailability in granulomatous tissue,” PLoS Computational Biology, vol. 3, no. 10, pp. 1909–1924, 2007. View at Publisher · View at Google Scholar · View at Scopus
  47. S. D. Chakravarty, G. Zhu, M. C. Tsai et al., “Tumor necrosis factor blockade in chronic murine tuberculosis enhances granulomatous inflammation and disorganizes granulomas in the lungs,” Infection and Immunity, vol. 76, no. 3, pp. 916–926, 2008. View at Publisher · View at Google Scholar · View at Scopus
  48. Y. Zhang, M. Broser, and W. N. Rom, “Activation of the interleukin 6 gene by Mycobacterium tuberculosis or lipopolysaccharide is mediated by nuclear factors NF-IL6 and NF-κB,” Proceedings of the National Academy of Sciences of the United States of America, vol. 91, no. 6, pp. 2225–2229, 1994. View at Google Scholar · View at Scopus
  49. M. S. Miranda, A. Breiman, S. Allain, F. Deknuydt, and F. Altare, “The tuberculous granuloma: an unsuccessful host defence mechanism providing a safety shelter for the bacteria?” Clinical and Developmental Immunology, vol. 2012, Article ID 139127, 14 pages, 2012. View at Publisher · View at Google Scholar
  50. B. M. Saunders, A. A. Frank, and I. M. Orme, “Granuloma formation is required to contain bacillus growth and delay mortality in mice chronically infected with Mycobacterium tuberculosis,” Immunology, vol. 98, no. 3, pp. 324–328, 1999. View at Publisher · View at Google Scholar · View at Scopus
  51. P. J. Cardona, R. Llatjos, S. Gordillo et al., “Evolution of granulomas in lungs of mice infected aerogenically with Mycobacterium tuberculosis,” Scandinavian Journal of Immunology, vol. 52, no. 2, pp. 156–163, 2000. View at Publisher · View at Google Scholar · View at Scopus
  52. J. L. Flynn, “Lessons from experimental Mycobacterium tuberculosis infections,” Microbes and Infection, vol. 8, no. 4, pp. 1179–1188, 2006. View at Publisher · View at Google Scholar · View at Scopus
  53. A. J. Lenaerts, D. Hoff, S. Aly et al., “Location of persisting mycobacteria in a Guinea pig model of tuberculosis revealed by r207910,” Antimicrobial Agents and Chemotherapy, vol. 51, no. 9, pp. 3338–3345, 2007. View at Publisher · View at Google Scholar · View at Scopus
  54. J. L. Flynn, S. V. Capuano, D. Croix et al., “Non-human primates: a model for tuberculosis research,” Tuberculosis, vol. 83, no. 1–3, pp. 116–118, 2003. View at Publisher · View at Google Scholar · View at Scopus
  55. F. Saxegaard, “Experimental infection of calves with an apparently specific goat-pathogenic strain of Mycobacterium paratuberculosis,” Journal of Comparative Pathology, vol. 102, no. 2, pp. 149–156, 1990. View at Google Scholar · View at Scopus
  56. J. D. Rodgers, N. L. Connery, J. McNair et al., “Experimental exposure of cattle to a precise aerosolised challenge of Mycobacterium bovis: a novel model to study bovine tuberculosis,” Tuberculosis, vol. 87, no. 5, pp. 405–414, 2007. View at Publisher · View at Google Scholar · View at Scopus
  57. D. R. Roach, H. Briscoe, K. Baumgart, D. A. Rathjen, and W. J. Britton, “Tumor necrosis factor (TNF) and a TNF-mimetic peptide modulate the granulomatous response to Mycobacterium bovis BCG infection in vivo,” Infection and Immunity, vol. 67, no. 10, pp. 5473–5476, 1999. View at Google Scholar · View at Scopus
  58. J. Daniel, C. Deb, V. S. Dubey et al., “Induction of a novel class of diacylglycerol acyltransferases and triacylglycerol accumulation in Mycobacterium tuberculosis as it goes into a dormancy-like state in culture,” Journal of Bacteriology, vol. 186, no. 15, pp. 5017–5030, 2004. View at Publisher · View at Google Scholar · View at Scopus
  59. C. Deb, C.-M. Lee, V. S. Dubey et al., “A novel in vitro multiple-stress dormancy model for mycobacterium tuberculosis generates a lipid-loaded, drug-tolerant, dormant pathogen,” PLoS ONE, vol. 4, no. 6, article e6077, 2009. View at Publisher · View at Google Scholar · View at Scopus
  60. U. Seitzer and J. Gerdes, “Generation and characterization of multicellular heterospheroids formed by human peripheral blood mononuclear cells,” Cells Tissues Organs, vol. 174, no. 3, pp. 110–116, 2003. View at Publisher · View at Google Scholar · View at Scopus
  61. K. A. Birkness, J. Guarner, S. B. Sable et al., “An in vitro model of the leukocyte interactions associated with granuloma formation in Mycobacterium tuberculosis infection,” Immunology and Cell Biology, vol. 85, no. 2, pp. 160–168, 2007. View at Publisher · View at Google Scholar · View at Scopus
  62. N. Kapoor, S. Pawar, T. D. Sirakova, C. Deb, W. L. Warren, and P. E. Kolattukudy, “Human granuloma in vitro model, for TB dormancy and resuscitation,” PLoS ONE, vol. 8, no. 1, article e53657, 2013. View at Publisher · View at Google Scholar
  63. H. Wang, Y. Maeda, Y. Fukutomi, and M. Makino, “An in vitro model of Mycobacterium leprae induced granuloma formation,” BMC Infectious Diseases, vol. 13, article 279, 2013. View at Publisher · View at Google Scholar
  64. M. P. Puissegur, C. Botanch, J.-L. Duteyrat, G. Delsol, C. Caratero, and F. Altare, “An in vitro dual model of mycobacterial granulomas to investigate the molecular interactions between mycobacteria and human host cells,” Cellular Microbiology, vol. 6, no. 5, pp. 423–433, 2004. View at Publisher · View at Google Scholar · View at Scopus